All type of patients: 3 trials - BOLERO-3 - TAMRAD - BOLERO-2
HR+ HER2-: 2 trials - TAMRAD - BOLERO-2
Patient trastuzumab-resistant, and previously treated by taxanes: 1 trials - BOLERO-3
Patients recurring or progressing after prior endocrine therapy : 2 trials - TAMRAD - BOLERO-2